NKGN   $0.1944  -65.25% Market Open

NKGen Biotech, Inc.
Total Cash 79.00K
totalCashPerShare 0.002
EBITDA -30.23M
Total Debt 28.09M
quickRatio 0.002
currentRatio 0.024
Total Revenue
debtToEquity
Revenue/Share
ROA -1.06845
ROE
grossProfits
freeCashflow 12.75M
operatingCashflow -21.54M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 37.46M
forwardPE
floatShares 16.30M
sharesOutstanding 35.36M
sharesShort 432.02K
sharesShortPriorMonth 680.88K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.42%
heldPercentInstitutions 0.10%
Short Ratio help_outline 1.14%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue -2.705
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -88.25M
trailingEps -3.42%
forwardEps
enterpriseToEbitda -1.24
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 21
lastUpdated Nov. 2, 2024, 6:40 a.m.